Tumor detection
Clinical development
Company
- Team
- Partners
- Investors
News & Events
Contact us

Leiden University Medical Center (LUMC) and Centre for Human Drug Research (CHDR)

Tumor detection
Clinical development
Company
- Team
- Partners
- Investors
News & Events
Contact us

English

Français

Leiden University Medical Center (LUMC) and Centre for Human Drug Research (CHDR)

SurgiMab > News & Events > News > SurgiMab launches clinical trial in patients with pancreatic or rectal cancer > Leiden University Medical Center (LUMC) and Centre for Human Drug Research (CHDR)

18 April 2016 Administrateur SurgiMabLeave a comment0

Previous Post
SurgiMab launches clinical trial in patients with pancreatic or rectal cancer

About SurgiMab

SurgiMAb develops injectable fluorescent conjugates to be used during Fluorescence-Guided Surgery (FGS) by oncology surgeons so they can clearly delineate tumors and visualize infra-clinical size nodules invisible to their naked eyes.

Latest news

SurgiMab will sponsor the next edition of the International Symposium on Fluorescence Guided Surgery, 2-3 Nov 2023 in Amsterdam
SurgiMab will participate to the conference “Optics in the Life Sciences” during the Optica Biophotonics Congress in Vancouver April 23 – 27, 2023

Home . Legal & credits